Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens

Purpose of the Protocol: * To prospectively identify cancer patients whose tumors express specific molecular markers targeted by therapeutic agents, for the purpose of selecting the most clinically appropriate anticancer therapy, including clinical trial opportunities. * To collect and analyze biospecimens from cancer patients, using primarily standard of care laboratory methods, for the purpose of determining the expression of specific genotypic and phenotypic disease markers of scientific and medical interest. * To create a protocol database, including case and disease stage-matched clinical and therapeutic history data in addition to patient biomarker profiles, to serve as: * a systematic collection of data for comparing patient data to clinical trial selection criteria for the purpose of informing a clinical investigative site of available clinical trials matching patient clinical status; * a collection of clinically matched, comprehensive molecular results for scientific and research and development applications.

Sex

All

Minimum age

18 Years

Inclusion Criteria:

1. Patients who have given informed consent in accordance with the methods and procedures of this study
2. Diagnosis of cancer requiring medical care
3. Age ≥18 years
4. Patients under oncology care of a participating site
5. ECOG performance status of 0-3
6. Sufficient clinical status for collection of biospecimen samples within usual care

Exclusion Criteria:

1. Patients considered minors in the jurisdiction where the protocol is conducted
2. Patients who are prisoners
3. Patients who are employees of the research site
4. Relatives of the principal investigator or any participating physician
5. Patients with decisional incapacity who cannot understand or comprehend the informed consent form and therefore cannot give informed consent